(19)
(11) EP 1 761 533 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
12.10.2011 Bulletin 2011/41

(45) Mention of the grant of the patent:
20.04.2011 Bulletin 2011/16

(21) Application number: 05771214.3

(22) Date of filing: 17.06.2005
(51) International Patent Classification (IPC): 
C07D 471/04(2006.01)
A61P 25/00(2006.01)
 A61K 31/439(2006.01)
(86) International application number:
PCT/EP2005/006566
(87) International publication number:
WO 2005/123732 (29.12.2005 Gazette 2005/52)

(54)

1-AZA-BICYCLO[3.3.1]NONANES

1-AZA-BICYCLO[3.3.1]NONANE

1-AZA-BICYCLO[3.3.1]NONANES

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
HR LV

(30) Priority: 18.06.2004 US 581020 P

(43) Date of publication of application:
14.03.2007 Bulletin 2007/11

(60) Divisional application:
10180067.0 / 2336129

(73) Proprietor: Novartis AG
4002 Basel (CH)

(72) Inventors:
  • FEUERBACH, Dominik
    79379 Müllheim (DE)
  • MÜLLER, Werner
    CH-3073 Gümligen (CH)
  • ROY, Bernard, Lucien
    CH-1700 Fribourg (CH)
  • TROXLER, Thomas, J.
    CH-4246 Wahlen b. Laufen (CH)
  • HURTH, Konstanze
    F-68300 Saint Louis (FR)
  • FREDERIKSEN, Mathias
    CH-4053 Basel (CH)

(74) Representative: Vögeli-Lange, Regina 
Novartis AG Corporate Intellectual Property
4002 Basel
4002 Basel (CH)


(56) References cited: : 
   
  • PATENT ABSTRACTS OF JAPAN vol. 016, no. 544 (C-1004), 13 November 1992 (1992-11-13) & JP 04 208267 A (MITSUI PETROCHEM IND LTD; others: 01), 29 July 1992 (1992-07-29)
  • ABOUL-ENEIN: "Synthesis and antiinflammatory properties of some 1-azabicyclo[3.3.1]nonanes" EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 11, no. 2, 1976, pages 133-137, XP009055418
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).